ES2094112T3 - Oligopeptidos y su uso para el diagnostico y vacunacion relacionados con el sida y el crs. - Google Patents

Oligopeptidos y su uso para el diagnostico y vacunacion relacionados con el sida y el crs.

Info

Publication number
ES2094112T3
ES2094112T3 ES88202248T ES88202248T ES2094112T3 ES 2094112 T3 ES2094112 T3 ES 2094112T3 ES 88202248 T ES88202248 T ES 88202248T ES 88202248 T ES88202248 T ES 88202248T ES 2094112 T3 ES2094112 T3 ES 2094112T3
Authority
ES
Spain
Prior art keywords
oligopeptides
sequence
diagnosis
crs
aids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88202248T
Other languages
English (en)
Inventor
Jaap Goudsmit
Robert Hans Meloen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stichting Centraal Diergeneeskundig Instituut
Academisch Ziekenhuis bij de Universiteit Van Amsterdam
Original Assignee
Stichting Centraal Diergeneeskundig Instituut
Academisch Ziekenhuis bij de Universiteit Van Amsterdam
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Centraal Diergeneeskundig Instituut, Academisch Ziekenhuis bij de Universiteit Van Amsterdam filed Critical Stichting Centraal Diergeneeskundig Instituut
Application granted granted Critical
Publication of ES2094112T3 publication Critical patent/ES2094112T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

LA INVENCION SE REFIERE A OLIGOPEPTIDOS QUE TIENEN UTILIDAD EN DIAGNOSIS Y VACUNACION FRENTE A DICHOS OLIGOPEPTIDOS. LOS OLIGOPEPTIDOS TIENEN UNA LONGITUD DE 8 A 17 AMINOACIDOS. LA SECUENCIA DE AMINOACIDOS CORRESPONDE A UNA SECUENCIA QUE OCURRE EN LA REGION V3 DE GP120 Y COMPRENDE LA SECUENCIA DE CONVERSION BETA GPC(R) EN LAS POSICIONES 312 - 314(315) O UNA SECUENCIA VARIANTE DE CONVERSION BETA, Y SECUENCIAS LATRALES DE AL MENOS UNO, Y PREFERIBLEMENTE AL MENOS DOS, AMINOACIDOS A AMBOS LADOS DE LA SECUENCIA DE CONVERSION BETA.
ES88202248T 1987-10-09 1988-10-07 Oligopeptidos y su uso para el diagnostico y vacunacion relacionados con el sida y el crs. Expired - Lifetime ES2094112T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8702403A NL8702403A (nl) 1987-10-09 1987-10-09 Oligopeptiden en gebruik daarvan voor diagnostische en vaccinatiedoeleinden voor aids en arc.

Publications (1)

Publication Number Publication Date
ES2094112T3 true ES2094112T3 (es) 1997-01-16

Family

ID=19850727

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88202248T Expired - Lifetime ES2094112T3 (es) 1987-10-09 1988-10-07 Oligopeptidos y su uso para el diagnostico y vacunacion relacionados con el sida y el crs.

Country Status (8)

Country Link
EP (2) EP0311219B1 (es)
JP (1) JPH03501968A (es)
AT (1) ATE141287T1 (es)
CA (1) CA1340914C (es)
DE (1) DE3855471T2 (es)
ES (1) ES2094112T3 (es)
NL (1) NL8702403A (es)
WO (1) WO1989003391A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01301699A (ja) * 1988-02-10 1989-12-05 Immulogic Pharmaceut Corp 難治性の感染症の治療用ペプチド
US5763160A (en) * 1988-02-12 1998-06-09 United Biomedical, Inc. Synthetic peptides and process of using same for the detection of antibodies to human immunodeficiency virus (HIV) gp120 envelope protein, diagnosis of AIDS and pre-AIDS conditions and as vaccines
CA1341285C (en) * 1988-02-12 2001-08-14 Chang Yi Wang Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines
US5562905A (en) * 1988-04-26 1996-10-08 E. I. Du Pont De Nemours And Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
IL91843A0 (en) * 1988-10-03 1990-06-10 Repligen Corp Hiv proteins and peptides useful in the diagnosis,prophylaxis aids or therapy of aids
SE9000333D0 (sv) * 1990-01-31 1990-01-31 Britta Wahren Monoklonal antikropp
EP0448095A1 (en) * 1990-03-21 1991-09-25 Wolf, Hans Joachim, Prof. Dr. Subregion of the retroviral ENV protein, DNA sequences encoding it and compositions for the diagnosis, prevention or therapy of retrovirus infections
US5914109A (en) * 1990-06-15 1999-06-22 New York University Heterohybridomas producing human monoclonal antibodies to HIV-1
WO1991019797A1 (en) * 1990-06-15 1991-12-26 New York University Heterohybridomas producing human monoclonal antibodies to hiv-1
CA2047073A1 (en) * 1990-07-19 1992-01-20 William J. Leanza Coconjugate vaccines comprising immunogenic protein, hiv related peptides, and anionic moieties
CA2047031A1 (en) * 1990-07-19 1992-01-20 Stephen Marburg Peptide-polysaccharide-protein conjugate vaccines
CA2047078A1 (en) * 1990-07-19 1992-01-20 Steven S. Bondy Cyclic hiv principal neutralizing determinant peptides
IL99077A0 (en) * 1990-08-13 1992-07-15 Merck & Co Inc New embodiments of the hiv principal neutralizing determinant and pharmaceutical compositions containing them
US5627035A (en) * 1990-08-22 1997-05-06 Syntello Vaccine Development Ab Peptides that block human immunodeficiency virus and methods of use thereof
CA2088788C (en) * 1990-08-22 2003-12-16 Tripep Ab Peptides that block human immunodeficiency virus infections and methods of use thereof
EP0554401A4 (en) * 1990-10-26 1996-10-30 New York Health Res Inst Neutralizing human monoclonal antibodies specific for the v3 loop and cd-4 binding site of hiv-1 gp120
EP0492920A1 (en) * 1990-12-24 1992-07-01 Merck & Co. Inc. Chimaeric influenza-HIV vaccine
US6139843A (en) * 1991-04-02 2000-10-31 Albert Einstein College Of Medicine Of Yeshiva University Peptide compositions for the treatment of HIV
JPH0570493A (ja) * 1991-05-31 1993-03-23 Chemo Sero Therapeut Res Inst ヒト免疫不全ウイルス（ｈｉｖ）関連免疫調製物
GB9318901D0 (en) * 1993-09-13 1993-10-27 Centre Nat Rech Scient Multiple branch peptide construction
WO2009008888A1 (en) * 2007-07-10 2009-01-15 Matthias Rath African swine virus polypeptides as vaccines and its therapeutic use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US779431A (en) * 1903-06-02 1905-01-10 American Tobacco Co Cigarette-machine.
CA1341620C (en) * 1984-10-18 2011-08-23 Luc Montagnier Envelope antigens of hiv-1
JPS63501716A (ja) * 1985-10-24 1988-07-14 サウスウエスト・ファウンデ−ション・フォア・バイオメディカル・リサ−チ 合成ペプチドおよびａｉｄｓおよびａｒｃの診断ならびにワクチン注射へのその使用

Also Published As

Publication number Publication date
JPH03501968A (ja) 1991-05-09
DE3855471T2 (de) 1996-12-19
EP0311219B1 (en) 1996-08-14
EP0389489A1 (en) 1990-10-03
ATE141287T1 (de) 1996-08-15
DE3855471D1 (de) 1996-09-19
NL8702403A (nl) 1989-05-01
CA1340914C (en) 2000-02-29
WO1989003391A1 (en) 1989-04-20
EP0311219A1 (en) 1989-04-12

Similar Documents

Publication Publication Date Title
ES2094112T3 (es) Oligopeptidos y su uso para el diagnostico y vacunacion relacionados con el sida y el crs.
DK0415850T3 (da) Bivalente metalsalte af 2-N,N-di(carboxymethyl)-amino-3-cyano-4-carboxymethyl-5-carboxythiophensyre, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem
NO883073D0 (no) 3-desmetyl-mevalonsyrederivater, fremgangsmaate til deres fremstilling samt deres anvendelse som mellomprodukter.
NO971889D0 (no) Forbindelser og sammensetninger for levering av aktive midler
MY107843A (en) Anti-viral compounds.
ES2042541T3 (es) Un procedimiento de preparacion de una formulacion farmaceutica de liberacion retardada que contiene goma de xantano.
WO1995033464A3 (en) Retroviral protease inhibitor combinations
IT8722481A0 (it) Polipeptidi immunologicamente attivi con una tossicita' alterata utili per la preparazione di un vaccino antipertosse.
DK84888A (da) Neisseria gonorrhoea-lectin, anvendeligt som vaccine og diagnostisk markoer, og midler til fremstilling af dette lectin
DK0885881T3 (da) Sulfonylalkanoylaminohydroxyethylaminosulfaminsyrer, der er anvendelige som retrovirale proteaseinhibitorer
DE3887014D1 (de) Nukleoside, ihre Herstellung und pharmazeutische Zusammenstellungen.
DK0482097T3 (da) Tensidpræparater og fremgangsmåder
DK482185A (da) Peptider, deres fremstilling og anvendelse som laegemidler
NO890187D0 (no) 2-(3,4-dihydroksyfenyl)etylaminer, deres fremstilling og anvendelse som farmasoeytika.
BR9506956A (pt) Composição farmacêutica antitussígena
ES2062529T3 (es) Uso de alcoholes alifaticos, de c-20 a c-26, para la realizacion de un medicamento destinado al tratamiento de infecciones virales.
DK103987D0 (da) Substituerede 1,3,4,9-tetrahydropyranooe3,4-baaindol-l-eddikesyrer, deres fremstilling og anvendelse som laegemidler
ES2054089T3 (es) Formulaciones orales liquidas.
DK486589A (da) Stabile oxapenem-3-carboxylsyrer og deres anvendelse som beta-lactamase-inhibitorer
NO920143L (no) Substituerte 2-imidazoliner og fremstilling og anvendelsederav
DK513188D0 (da) Aminosyreestre, deres fremstilling og anvendelse som laegemidler
DK284588D0 (da) Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler.
ES2095899T3 (es) Peptidos de la proteina gag de vih, su preparacion y uso.
IT1291895B1 (it) Preparazione farmaceutica fluida a base di nimesulide per uso orale e rinofaringeo
NO901169D0 (no) Azol-1-alkanamider som anti-arrytmiske midler og fremstilling derav.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 311219

Country of ref document: ES